Mercapto derivatives as inhibitors of cyclooxygenases

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/155 (2006.01) A61K 31/395 (2006.01)

Patent

CA 2247121

This invention is directed to a pharmacologically acceptable composition for inhibiting cyclooxygenase in a mammal, which includes a mercapto derivative and a pharmaceutically acceptable carrier. The invention also concerns a method of inhibiting cyclooxygenase and treating various conditions where there is an advantage in inhibiting prostaglandins biosynthesis. The method includes the step of administering to a mammal a mercapto derivative in pure form or in a pharmaceutically acceptable carrier.

Cette invention concerne une composition acceptable sur le plan pharmacologique, laquelle composition permet d'inhiber la cyclo-oxygénase chez les mammifères et comprend un dérivé mercapto ainsi qu'un véhicule acceptable sur le plan pharmaceutique. Cette invention concerne également un procédé d'inhibition de cyclo-oxygénase et de traitement de divers états où l'on a intérêt a inhiber la biosynthèse de prostaglandine. Ce procédé consiste à administrer à un mammifère un dérivé mercapto sous sa forme pure ou dans un véhicule acceptable sur le plan pharmaceutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mercapto derivatives as inhibitors of cyclooxygenases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mercapto derivatives as inhibitors of cyclooxygenases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mercapto derivatives as inhibitors of cyclooxygenases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1593972

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.